YENEY ANDRADE: Open Payments
NPI 1801136403 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,825 in 16 payments from 9 companies in 2025. Trend: 2023 $284 · 2024 $5,841 · 2025 $3,825
Consulting: $2,616Food & beverage: $667Travel & lodging: $543
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $3,330 |
| Ardelyx, Inc. | 2 | $198 |
| Phathom Pharmaceuticals, Inc. | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 1 | $63 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $38 |
| Janssen Biotech, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: IBSRELA, DUPIXENT, VOQUEZNA, ZENPEP, XIFAXAN, TREMFYA, RINVOQ.
Industry payments across FL — which companies pay providers there.
